plasminogen in English
Tissue plasminogen activator and, to a lesser degree, urokinase are serine proteases which convert plasminogen to plasmin.
Use "plasminogen" in a sentence
1. Modified plasminogen activator inhibitor type-1 molecule and methods based thereon
2. C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
3. Haematology See Plasminogen Activation Immunology See Complement Activation, Lymphocyte Activation, Macrophage Activation, T cell Activation
4. 28 In summary, several approaches have produced engineered plasminogen activators with an increased thrombolytic potency in experimental animal models.
5. Describe its similarity to plasminogen, its capacity to delay Coagulum or embolus destruction and highlight its structural and functional similarity to lipid metabolism.
6. 26 But Dr. Marian LaMonte, co-director of the Brain Attack Team, began intravenously administering a drug called tissue plasminogen activator (t-PA).
7. Patients with acute ischemic stroke in the Basilar artery territory should receive intravenous alteplase (recombinant tissue plasminogen activator, tPA) if they qualify according to accepted criteria.
8. In these patients diagnosis and regression of thromboemboli following systemic intravenous lysis therapy with recombinant tissue-type plasminogen activator (rt-PA) was documented by transesophageal echocardiography (TEE).
9. Plasminogen activator (PA) expression plays an important role in smooth muscle cell (SMC) migration and may therefore contribute to mechanical force-induced Arterialization of vein grafts
10. There are three main types of blood thinners that patients commonly take: Anticoagulants like warfarin or heparin, antiplatelet drugs like aspirin, and fibrinolytics like tPA (tissue plasminogen activator).
11. Alteplase (Activase® rt-PA) for acute ischemic stroke: special precautions for new indication Alteplase is a serine protease that binds to fibrin in a thrombus or blood clot resulting in conversion of plasminogen to plasmin and initiation of local fibrinolysis.
12. To assess blood coagulation and fibrinolytic activity in congenital heart disease, the platelet count, plasma clotting times (thromboplastin time, partial thromboplastin time, thrombin time) as well as the coagulation (thrombelastography) and activity of the proactivator-plasminogen-complex of whole blood were determined prospectively in 500 patients; 55% of whom had acyanotic and 45% cyanotic lesions.